Mynavi leads $7.5M Series B for healthcare edtech Virohan
The Haryana-based company, listed under EdTech – Healthcare, closed the round with Mynavi as lead investor in the 16–29 December 2025 window of StartupTalky's funding tracker.
Virohan, a Haryana-based company operating in the healthcare education space, has raised $7.5M in a Series B round led by Mynavi, according to StartupTalky's running tally of Indian startup funding. The deal appears in the tracker's December 2025 listing covering the 16 to 29 December window.
The company sits in the EdTech – Healthcare category, a segment where the tracker shows comparatively few cheques. Virohan's registered office is in Faridabad, Haryana, per its own corporate disclosures.
The round is one of the larger education-technology deals recorded in the tracker's December 2025 tables, though it is dwarfed by the month's headline financings in other sectors. The same 16–29 December window lists Transcon Ind at $27.9M, Coreel at $30M and Digantara at $50M — all Series B or later — alongside $75M in conventional debt for True Balance and $4.42B post-IPO for Shriram Finance. Virohan's $7.5M sits in the middle of that pack.
Within education specifically, December looked busier than a single round suggests. The tracker records Uolo, a Haryana-based K-12 edtech, raising $7M in a Series A led by Blume Venture; Newron, a Delhi K-12 company, at $4.44M in seed funding led by AFL; ENpower, a Maharashtra K-12 edtech, closing an undisclosed seed round with Tata ClassEdge; and CuePilot, a West Bengal K-12 venture, at $1.8M in seed funding from Unilazer Ventures. Virohan is the only healthcare-focused education company among them.
What the new capital will fund is not stated in the source. Nor does the tracker disclose the valuation at which the Series B was struck, the identity of any participating investors beyond lead backer Mynavi, or the composition of Virohan's prior rounds. Japanese strategic investors have become more visible in Indian education and skilling deals in recent years, but the tracker does not characterise Mynavi's motivation or stake.
For a sector that has spent much of the past two years in retreat — with layoffs and consolidation dominating edtech headlines — a Series B of this size is a reminder that capital has not vanished so much as narrowed. Buyers are now concentrated in categories with a clearer line to employment: healthcare training, semiconductor skills, vocational certification. Virohan's placement in that bucket, rather than in consumer test-prep, is likely no accident.